Cadila Healthcare to sell 49% stake of Windlas Healthcare

30 Apr 2020 Evaluate
Cadila Healthcare has signed the Definitive Agreement for sale of 2,31,33,717 equity shares of Rs 10 each fully paid?up, representing 49% of the total paid?up share capital of Windlass Healthcare (WHPL) to Windlas Biotech (WBPL). The board of the company at its meeting held on April 30, 2020, approved the same.
 
Consequent to above divestment and upon completion of the transaction in relation to the sale of the said equity shares, the company shall cease to hold any equity shares in WHPL. The transaction is expected to be completed within 10 business days.
 
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.


Zydus Lifesciences Share Price

913.85 -4.50 (-0.49%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×